nytimes.com / .nytimes-com-health

Robert F. Kennedy Jr.'s assault may have dealt lasting damage to the agency, experts fear, with harsh consequences for public health.

Patients are flooding medical practices with reports of the telltale signs of Covid and questions about whether they will be able to get vaccinated.

A network of hospitals and cancer centers dedicated to early phase trials of novel treatments will no longer receive federal funding.

The country's largest pharmacy chain said it needed a C.D.C. panel to recommend the shots before it could offer them nationwide.

After six months of turmoil, the loss of the new director and a round of high-profile resignations marks a new low, some employees said.

Lawyers for the agency's chief, Susan Monarez, insist that the impasse with Health Secretary Robert F. Kennedy Jr. can only be resolved by President Trump.

A pilot program in six states will use a tactic employed by private insurers that has been heavily criticized for delaying and denying medical care.

Susan Monarez's brief tenure was roiled by Robert F. Kennedy Jr.'s decisions to overhaul vaccine policy and gut a critical advisory panel.

The agency's fall recommendations underscore the goals of Health Secretary Robert F. Kennedy Jr. to limit access to the vaccines, which he has long opposed.

A new study reveals some of the crucial molecular steps on the path to bipedalism.